Skip to content

Upper Airway Stability During Wakefulness and Sleep

Upper Airway Stability During Wakefulness and Sleep

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03893552
Enrollment
100
Registered
2019-03-28
Start date
2016-03-01
Completion date
2016-12-30
Last updated
2019-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea Syndromes, Snoring

Keywords

Negative expiratory pressure, sleep apnea, Snoring, Sleep-disordered breathing

Brief summary

Negative expiratory pressure is a technique that has been the focus of many studies in the last few years. Airway response to the application of a negative expiratory pressure (NEP) can be used to detect the presence of upper airway collapsibility. In normal subjects, an increase in expiratory flow is observed while in patients with collapsible upper airway, the flow will show a transient decrease due to airway collapse. The objectives of this study will be initially to investigate the diagnostic utility of this technique as a noninvasive measurement of the stability of the upper airway in sleep-related breathing disorders. Secondly, we aim to see the sites of airway obstructions, discovered by NEP, through nasal endoscopy. Finally, we aim at testing the utility of NEP technique in the evaluation of therapeutic response. For this purpose, we will apply it in patients before and after airway stabilization interventions like ENT surgery, oropharyngeal exercises, orthodontic mandibular advancement electrical stimulation of the hypoglossal nerve.

Interventions

DEVICENegative expiratory pressure

Using a cough assist, a negative expiratory pressure will be applied while recording the respiratory flow in patients suffering from sleeping disorders or snoring.

Sponsors

Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

\-

Exclusion criteria

* Patients with COPD

Design outcomes

Primary

MeasureTime frameDescription
Measure of Flow limitation during NEP applicationmeasurement done immediately after inclusion, one timesee above, using pneumotachograph

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026